News for Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics (FLGT) has successfully obtained CE certification within the European Union under the In Vitro Diagnostic Regulation 2017/746. This certificati

Fulgent Genetics, Inc. (NASDAQ: FLGT) (”œFulgent” or the ”œCompany”), a technology-based company with a well-established laboratory services business and

Fulgent Genetics (FLGT) to release Q2 2025 financial results on August 1, 2025. Conference call scheduled at 8:30 AM ET to discuss results with investor

NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œCo

PR NewswireNEW YORK, July 2, 2025 NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics,

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œC

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œC

PR NewswireNEW YORK, June 22, 2025 NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œC

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œC

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œCo

PR NewswireNEW YORK, June 7, 2025 NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics,

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œC

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œC

PR NewswireNEW YORK, June 1, 2025 NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics,

PR NewswireNEW YORK, May 26, 2025 NEW YORK, May 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics,

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Ge

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (”œFulgent” or the ”œCom

Shares of Fulgent Genetics Inc (FLGT) fell 3.03% in mid-day trading on May 21. The stock reached an intraday low of $20.54, before recovering slightly to $20.